ProLogium Appoints Antony Sheriff, CEO of Rimac Group, to Board of Directors
Globe Newswire (Mon, 24-Aug 9:31 AM ET)
PRNewswire (Sun, 23-Aug 3:00 PM ET)
Business Wire (Wed, 19-Aug 1:19 PM ET)
Globe Newswire (Tue, 28-Jul 9:00 AM ET)
TDAC Announces ProLogium's Filing of F-4 As Continuing Momentum Towards Merger
PRNewswire (Mon, 6-Jul 9:52 AM ET)
TDAC Announces Very Successful Share Redemption Results in Connection with Extension Vote
PRNewswire (Mon, 22-Jun 7:05 AM ET)
Market Chameleon (Wed, 27-May 7:10 AM ET)
Market Chameleon (Wed, 27-May 4:38 AM ET)
Translational Development Acquisition Corp is a newly organized blank check company.
Translational Dev Acq trades on the NASDAQ stock market under the symbol TDAC.
As of August 28, 2026, TDAC stock price climbed to $10.84 with 5,229 million shares trading.
TDAC has a beta of 0.04, meaning it tends to be less sensitive to market movements. TDAC has a correlation of 0.07 to the broad based SPY ETF.
TDAC has a market cap of $209.31 million. This is considered a Small Cap stock.
TDAC has underperformed the market in the last year with a return of +4.9%, while the SPY ETF gained +20.1%. In the last 3 month period, TDAC fell short of the market, returning +1.0%, while SPY returned +2.8%. However, in the most recent 2 weeks TDAC has outperformed the stock market by returning -0.1%, while SPY returned -1.1%.
TDAC support price is $10.80 and resistance is $10.87 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that TDAC shares will trade within this expected range on the day.
